Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.95 |
| ▸ | CES2 | O00748 | 1/20 | 0.65 |
| ▸ | CES1 | P23141 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.53 |
| ▸ | FEN1 | P39748 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29369803 | 0.97 | ALDH1A1 (1.00) | ALDH1A1CES2CES1TSHRALOX15 | |
| SCHEMBL29004189 | 0.97 | ALDH1A1 (1.00) | ALDH1A1CES2CES1TSHRALOX15 | |
| SCHEMBL29518925 | 0.97 | ALDH1A1 (1.00) | ALDH1A1CES2CES1TSHRALOX15 | |
| SCHEMBL8482425 | 0.97 | ALDH1A1 (1.00) | ALDH1A1CES2CES1TSHRALOX15 | |
| SCHEMBL367 | 0.97 | ALDH1A1 (1.00) | ALDH1A1CES2CES1TSHRALOX15 | |
| SCHEMBL10492061 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CES2CES1TSHRALOX15 | |
| Hydrochloric Acid SCHEMBL784866 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CES2CES1TSHRALOX15 | |
| Fluoride SCHEMBL6444932 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CES2CES1TSHRALOX15 | |
| SCHEMBL6915337 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CES2CES1TSHRALOX15 | |
| SCHEMBL11768054 | 0.95 | ALDH1A1 (0.95) | ALDH1A1CES2CES1TSHRALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114843405-A | Chlorine-containing organic potassium salt modified perovskite solar cell electron transport layer, perovskite solar cell and preparation method thereof | 武汉理工大学 | 2022-08-02 | — | — | CN | claimed |
| EP-2383275-A1 | METHOD FOR SYNTHESIZING O-DIPHENYLPHOSPHINO BENZOIC ACID | Sinomax Chemical Technology Co., Ltd (CN) | 2011-11-02 | — | — | EP | claimed |
| US-20110077426-A1 | METHOD FOR SYNTHESIS OF O-DIPHENYLPHOSPHINOBENZOIC ACID | SINOMAX CHEMICAL TECHNOLOGY CO. LTD. (CN) | 2011-03-31 | — | — | US | claimed |
| CN-114843405-A | Chlorine-containing organic potassium salt modified perovskite solar cell electron transport layer, perovskite solar cell and preparation method thereof | 武汉理工大学 | 2022-08-02 | — | — | CN | disclosed |
| CN-104557646-B | Produce the commercial run of arylsulfur pentafluorides | 宇部兴产株式会社 | 2017-08-29 | — | — | CN | disclosed |
| CN-106946755-A | Produce the commercial run of arylsulfur pentafluorides | 宇部兴产株式会社 | 2017-07-14 | — | — | CN | disclosed |
| CN-104557646-A | Industrial methods for producing arylsulfur pentafluorides | UBE INDUSTRIES | 2015-04-29 | — | — | CN | disclosed |
| CN-103380110-A | Industrial process for the production of arylsulfur pentafluorides | UBE INDUSTRIES | 2013-10-30 | — | — | CN | disclosed |
| EP-2383275-A1 | METHOD FOR SYNTHESIZING O-DIPHENYLPHOSPHINO BENZOIC ACID | Sinomax Chemical Technology Co., Ltd (CN) | 2011-11-02 | — | — | EP | disclosed |
| US-20110077426-A1 | METHOD FOR SYNTHESIS OF O-DIPHENYLPHOSPHINOBENZOIC ACID | SINOMAX CHEMICAL TECHNOLOGY CO. LTD. (CN) | 2011-03-31 | — | — | US | disclosed |
| US-20100160351-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING HYPERURICEMIA AND RELATED DISORDERS | NUON THERAPEUTICS, INC. (US) | 2010-06-24 | — | — | US | disclosed |
| EP-0278176-B1 | Compounds having antitumour and antibacterial properties | WARNER LAMBERT CO (US) | 1994-03-09 | — | — | EP | disclosed |
| US-5281620-A | Alkyl substituted xanthenone-4-acetic acid | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 1994-01-25 | — | — | US | disclosed |
| US-4924004-A | 1-phenyl-2-aminocarbonylindole compounds, preparation thereof and pharmaceutical compositions containing them | KALI-CHEMIE PHARMA GMBH (DE) | 1990-05-08 | — | — | US | disclosed |
| US-4803198-A | ANTIARRHYTHMIA AGENTS | KALI-CHEMIE PHARMA GMBH (DE) | 1989-02-07 | — | — | US | disclosed |
| EP-0278176-A2 | Compounds having antitumour and antibacterial properties | WARNER-LAMBERT COMPANY (US) | 1988-08-17 | — | — | EP | disclosed |
| US-3989746-A | ANALGESICS, ANTIINFLAMMATORY AGENTS | IKEDA MOHANDO CO., LTD. (JA) | 1976-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160351-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING HYPERURICEMIA AND RELATED DISORDERS | XDH, SLC10A1, SLC10A6 | ALDH1A1 488/4885CES2 1046/4885CES1 314/4885 |
| US-20110077426-A1 | METHOD FOR SYNTHESIS OF O-DIPHENYLPHOSPHINOBENZOIC ACID | PLCB1, DCPS, POF1B | ALDH1A1 2332/4885CES2 1862/4885CES1 2717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.